Hematology

Five Prime Therapeutics publishes Phase 1 bemarituzumab study data in the Journal of Clinical Oncology

The AACR Annual Meeting covers the best in cutting edge cancer research and care

Purdue researchers identify a process that controls stem cells' ability to differentiate, and detail how aberrations in that process can lead to cells becoming cancerous

CicloMed shares Phase 1 results of its lead candidate in bladder cancer

Acelarin receives positive opinion for Orphan Drug Designation in the EU for the treatment of biliary tract cancer

Fennec Pharmaceuticals receives EMA validation for sodium thiosulfate Marketing Authorization Application

Magenta Therapeutics presents new research at the Transplant and Cellular Therapy Annual Meeting

Agreement focuses on tafasitamab for the treatment of B cell malignancies

Bio-Rad’s ddPCR technology provides faster, more accurate diagnoses

Drug can affect non-Hodgkin’s lymphoma cell lines

Two different trials in prostate cancer see encouraging patient responses

NuCana announces first patients dosed in Phase 3 Acelarin (NUC-1031) study for biliary tract cancer